Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Treatments for Depression: Drug vs. Psychotherapy Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Treatments for Depression: Drug vs. Psychotherapy conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Treatments for Depression: Drug vs. Psychotherapy Clinical research trials and Treatments for Depression: Drug vs. Psychotherapy medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Treatments for Depression: Drug vs. Psychotherapy. Treatments for Depression: Drug vs. Psychotherapy Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Treatments for Depression: Drug vs. Psychotherapy clinical trial. Subjects often receive the most expert healthcare possible for their Treatments for Depression: Drug vs. Psychotherapy condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "T" Clinical Trials Conditions > Treatments for Depression: Drug vs. Psychotherapy

Treatments for Depression: Drug vs. Psychotherapy



Treatments for Depression: Drug vs. Psychotherapy

For Condition: Depression
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to compare supportive expressive psychodynamic therapy to antidepressant medication plus Clinical Management for the treatment of patients with Major Depressive Disorder (MDD). A second goal is to evaluate the long-term effects of these 2 treatments on the recurrence of depression.
Details: MDD is one of the most prevalent psychiatric disorders. Different forms of psychotherapy for depression have been found effective. This study compares a form of dynamic psychotherapy called supportive-expressive psychotherapy to medication and to placebo. Participants are evaluated on 2 occasions, 1 week apart, before they are randomly assigned to receive either supportive-expressive psychotherapy, sertraline (Zoloft) (followed by venlafaxine [Effexor] if patients do not respond to sertraline), or placebo. The active phase of treatment lasts 4 months. The frequency of patients' visits depends on the assigned treatment. Patients who are randomized to receive medication or placebo are initially evaluated on a weekly basis, then less often, depending on the rate of symptomatic improvement. Patients who are randomized to psychotherapy are evaluated twice a week for the first 4 weeks, then once a week for the remaining 12 weeks. At the end of the first 16 weeks of treatment, patients are thoroughly evaluated. Those who have responded to treatment are assigned to a continuation phase and are seen once a month for another 16 weeks. At the end of the 16-week continuation phase, patients are again evaluated and all treatments are stopped. Follow-up continues every 3 months for up to 2 years to ensure that the patients' depression remains under control.
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Major Depressive Disorder diagnosis Exclusion criteria: - Psychotic or bipolar disorder diagnosis - Substance dependence in the last 6 months
Total Enrollment: 180

Location and Contact Information:

University of Pennsylvania *Recruiting*
Philadelphia,  Pennsylvania,  19104
United States
Recruiting Kim  Marin 215-662-2552


Additional Information:
Study ID Numbers:  61410-01A1; 
Study Start Date: November 2001
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00043550

Other Depression Studies:
1. Examination of a Soy-Based Supplement for Major Depression

2. Multiphase Efficacy Study of venlafaxine ER to Treat Recurrent Depression

3. Transcranial magnetic stimulation in depression

4. Therapy for Depression with Co-occurring Panic or Anxiety Symptoms

5. Preventing the Return of Depression in Elderly Patients

Related Studies:

Other Depression Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials

Treatments for Depression: Drug vs. Psychotherapy
Modify your Search

  Other Depression Clinical Trials
  Other Pennsylvania Clinical Trials
  Other Philadelphia Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103